Behaviors of Glioblastoma Cells in in Vitro Microenvironments
- PMID: 30643153
- PMCID: PMC6331579
- DOI: 10.1038/s41598-018-36347-7
Behaviors of Glioblastoma Cells in in Vitro Microenvironments
Abstract
Glioblastoma (GBM) is the most malignant and highly aggressive brain tumor. In this study, four types of typical GBM cell lines (LN229, SNB19, U87, U251) were cultured in a microfabricated 3-D model to study their in vitro behaviors. The 3-D in vitro model provides hollow micro-chamber arrays containing a natural collagen interface and thus allows the GBM cells to grow in the 3-D chambers. The GBM cells in this model showed specific properties on the aspects of cell morphology, proliferation, migration, and invasion, some of which were rarely observed before. Furthermore, how the cells invaded into the surrounding ECM and the corresponding specific invasion patterns were observed in details, implying that the four types of cells have different features during their development in cancer. This complex in vitro model, if applied to patient derived cells, possesses the potential of becoming a clinically relevant predictive model.
Conflict of interest statement
The authors declare no competing interests.
Figures






Similar articles
-
The mode and dynamics of glioblastoma cell invasion into a decellularized tissue-derived extracellular matrix-based three-dimensional tumor model.Sci Rep. 2018 Mar 15;8(1):4608. doi: 10.1038/s41598-018-22681-3. Sci Rep. 2018. PMID: 29545552 Free PMC article.
-
Tumor microenvironment tenascin-C promotes glioblastoma invasion and negatively regulates tumor proliferation.Neuro Oncol. 2016 Apr;18(4):507-17. doi: 10.1093/neuonc/nov171. Epub 2015 Aug 27. Neuro Oncol. 2016. PMID: 26320116 Free PMC article.
-
Bioengineered 3D brain tumor model to elucidate the effects of matrix stiffness on glioblastoma cell behavior using PEG-based hydrogels.Mol Pharm. 2014 Jul 7;11(7):2115-25. doi: 10.1021/mp5000828. Epub 2014 Apr 29. Mol Pharm. 2014. PMID: 24712441
-
Astrocytes, the rising stars of the glioblastoma microenvironment.Glia. 2019 May;67(5):779-790. doi: 10.1002/glia.23520. Epub 2018 Sep 21. Glia. 2019. PMID: 30240060 Review.
-
Integrating the glioblastoma microenvironment into engineered experimental models.Future Sci OA. 2017 Mar 24;3(3):FSO189. doi: 10.4155/fsoa-2016-0094. eCollection 2017 Aug. Future Sci OA. 2017. PMID: 28883992 Free PMC article. Review.
Cited by
-
Editorial: Immunosuppression mechanisms and immunotherapy strategies in glioblastoma.Front Cell Neurosci. 2024 Apr 25;18:1411330. doi: 10.3389/fncel.2024.1411330. eCollection 2024. Front Cell Neurosci. 2024. PMID: 38725447 Free PMC article. No abstract available.
-
CADD-based discovery of novel oligomeric modulators of PKM2 with antitumor activity in aggressive human glioblastoma models.Heliyon. 2025 Jan 24;11(3):e42238. doi: 10.1016/j.heliyon.2025.e42238. eCollection 2025 Feb 15. Heliyon. 2025. PMID: 39959478 Free PMC article.
-
NFBTA: A Potent Cytotoxic Agent against Glioblastoma.Molecules. 2019 Jun 29;24(13):2411. doi: 10.3390/molecules24132411. Molecules. 2019. PMID: 31261921 Free PMC article.
-
In vivo antiangiogenic effect of nimbolide, trans-chalcone and piperine for use against glioblastoma.BMC Cancer. 2023 Nov 30;23(1):1173. doi: 10.1186/s12885-023-11625-4. BMC Cancer. 2023. PMID: 38036978 Free PMC article.
-
Ruthenacarborane and Quinoline: A Promising Combination for the Treatment of Brain Tumors.Molecules. 2021 Jun 22;26(13):3801. doi: 10.3390/molecules26133801. Molecules. 2021. PMID: 34206482 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical